343 related articles for article (PubMed ID: 21841540)
21. Ex-vivo normothermic perfusion in renal transplantation: past, present and future.
Yong C; Hosgood SA; Nicholson ML
Curr Opin Organ Transplant; 2016 Jun; 21(3):301-7. PubMed ID: 27145197
[TBL] [Abstract][Full Text] [Related]
22. Machine perfusion as a tool to select kidneys recovered from uncontrolled donors after cardiac death.
Reznik ON; Bagnenko SF; Loginov IV; Iljina VA; Ananyev AN; Eremich SV; Moysyuk YG
Transplant Proc; 2008 May; 40(4):1023-6. PubMed ID: 18555105
[TBL] [Abstract][Full Text] [Related]
23. Machine perfusion versus cold storage for preservation of kidneys from expanded criteria donors after brain death.
Treckmann J; Moers C; Smits JM; Gallinat A; Maathuis MH; van Kasterop-Kutz M; Jochmans I; Homan van der Heide JJ; Squifflet JP; van Heurn E; Kirste GR; Rahmel A; Leuvenink HG; Pirenne J; Ploeg RJ; Paul A
Transpl Int; 2011 Jun; 24(6):548-54. PubMed ID: 21332580
[TBL] [Abstract][Full Text] [Related]
24. Hepatic steatosis and normothermic perfusion-preliminary experiments in a porcine model.
Jamieson RW; Zilvetti M; Roy D; Hughes D; Morovat A; Coussios CC; Friend PJ
Transplantation; 2011 Aug; 92(3):289-95. PubMed ID: 21681143
[TBL] [Abstract][Full Text] [Related]
25. The influence of storage temperature during machine perfusion on preservation quality of marginal donor livers.
Olschewski P; Gass P; Ariyakhagorn V; Jasse K; Hunold G; Menzel M; Schöning W; Schmitz V; Neuhaus P; Puhl G
Cryobiology; 2010 Jun; 60(3):337-43. PubMed ID: 20233587
[TBL] [Abstract][Full Text] [Related]
26. Kidney transplantation from non-heart-beating donors after oxygenated low-flow machine perfusion preservation with histidine-tryptophan-ketoglutarate solution.
Minor T; Sitzia M; Dombrowski F
Transpl Int; 2005 Jan; 17(11):707-12. PubMed ID: 15717215
[TBL] [Abstract][Full Text] [Related]
27. Use of ex vivo normothermic machine perfusion after normothermic regional perfusion to salvage a poorly perfused DCD kidney.
Georgiades F; Hosgood SA; Butler AJ; Nicholson ML
Am J Transplant; 2019 Dec; 19(12):3415-3419. PubMed ID: 31355509
[TBL] [Abstract][Full Text] [Related]
28. The superior results of living-donor renal transplantation are not completely caused by selection or short cold ischemia time: a single-center, multivariate analysis.
Roodnat JI; van Riemsdijk IC; Mulder PG; Doxiadis I; Claas FH; IJzermans JN; van Gelder T; Weimar W
Transplantation; 2003 Jun; 75(12):2014-8. PubMed ID: 12829903
[TBL] [Abstract][Full Text] [Related]
29. Kidney from uncontrolled donors after cardiac death with one hour warm ischemic time: resuscitation by extracorporal normothermic abdominal perfusion "in situ" by leukocytes-free oxygenated blood.
Reznik O; Skvortsov A; Loginov I; Ananyev A; Bagnenko S; Moysyuk Y
Clin Transplant; 2011; 25(4):511-6. PubMed ID: 20973824
[TBL] [Abstract][Full Text] [Related]
30. Re: Renal transplantation after ex vivo normothermic perfusion: the first clinical study.
Goldfarb DA
J Urol; 2013 Oct; 190(4):1334. PubMed ID: 24029344
[No Abstract] [Full Text] [Related]
31. Static normothermic preservation of renal allografts using a novel nonphosphate buffered preservation solution.
Kay MD; Hosgood SA; Harper SJ; Bagul A; Waller HL; Rees D; Nicholson ML
Transpl Int; 2007 Jan; 20(1):88-92. PubMed ID: 17181658
[TBL] [Abstract][Full Text] [Related]
32. Ex-vivo machine perfusion for kidney preservation.
Hamar M; Selzner M
Curr Opin Organ Transplant; 2018 Jun; 23(3):369-374. PubMed ID: 29697462
[TBL] [Abstract][Full Text] [Related]
33. Modified perfusion fluid for renal transplantation in developing countries: our initial experience.
Islam MK; Rahman AT; Arif NU; Bhuiyan AK; Islam MM; Khan SA; Rahman AM
Transplant Proc; 2010 Jun; 42(5):1531-5. PubMed ID: 20620469
[TBL] [Abstract][Full Text] [Related]
34. The use of in-situ normothermic extracorporeal perfusion and leukocyte depletion for resuscitation of human donor kidneys.
Reznik O; Bagnenko S; Scvortsov A; Loginov I; Ananyev A; Senchik K; Moysyuk Y
Perfusion; 2010 Sep; 25(5):343-8. PubMed ID: 20627941
[TBL] [Abstract][Full Text] [Related]
35. Ex-vivo normothermic liver perfusion: an update.
Vogel T; Brockmann JG; Friend PJ
Curr Opin Organ Transplant; 2010 Apr; 15(2):167-72. PubMed ID: 20186059
[TBL] [Abstract][Full Text] [Related]
36. Role of machine perfusion preservation in kidney transplantation from non-heartbeating donors.
Matsuno N; Sakurai E; Uchiyama M; Kozaki K; Miyamoto K; Kozaki M; Nagao T
Clin Transplant; 1998 Feb; 12(1):1-4. PubMed ID: 9541415
[TBL] [Abstract][Full Text] [Related]
37. A prospective controlled trial of cold-storage versus machine-perfusion preservation in cadaveric renal transplantation.
Merion RM; Oh HK; Port FK; Toledo-Pereyra LH; Turcotte JG
Transplantation; 1990 Aug; 50(2):230-3. PubMed ID: 2382290
[TBL] [Abstract][Full Text] [Related]
38. Dual-kidney transplants: long-term results.
Alfrey EJ; Boissy AR; Lerner SM;
Transplantation; 2003 Apr; 75(8):1232-6. PubMed ID: 12717208
[TBL] [Abstract][Full Text] [Related]
39. Machine perfusion preservation for kidney grafts with a high creatinine from uncontrolled donation after cardiac death.
Matsuno N; Konno YN; Jyojima Y; Akashi I; Iwamoto H; Hama K; Hiirano T; Nagao T
Transplant Proc; 2010; 42(1):155-8. PubMed ID: 20172304
[TBL] [Abstract][Full Text] [Related]
40. Prostaglandin E1 influences pulsatile preservation characteristics and early graft function in expanded criteria donor kidneys.
Polyak MM; Arrington BO; Stubenbord WT; Kapur S; Kinkhabwala M
J Surg Res; 1999 Jul; 85(1):17-25. PubMed ID: 10383833
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
